Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP917856.RAwifiyhNSrlH5bZKJQ4v71h4e4PDwEA_Ej8F3CHybgEE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP917856.RAwifiyhNSrlH5bZKJQ4v71h4e4PDwEA_Ej8F3CHybgEE130_assertion type Assertion NP917856.RAwifiyhNSrlH5bZKJQ4v71h4e4PDwEA_Ej8F3CHybgEE130_head.
- NP917856.RAwifiyhNSrlH5bZKJQ4v71h4e4PDwEA_Ej8F3CHybgEE130_assertion description "[The general lack of GR in adenocarcinomas contrasts with the high percentage of SCCs and HCCs expressing GR, and, along with the generation of chemoresistance by DEX, warrants prospective study of the effects of steroids on these cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP917856.RAwifiyhNSrlH5bZKJQ4v71h4e4PDwEA_Ej8F3CHybgEE130_provenance.
- NP917856.RAwifiyhNSrlH5bZKJQ4v71h4e4PDwEA_Ej8F3CHybgEE130_assertion evidence source_evidence_literature NP917856.RAwifiyhNSrlH5bZKJQ4v71h4e4PDwEA_Ej8F3CHybgEE130_provenance.
- NP917856.RAwifiyhNSrlH5bZKJQ4v71h4e4PDwEA_Ej8F3CHybgEE130_assertion SIO_000772 18269582 NP917856.RAwifiyhNSrlH5bZKJQ4v71h4e4PDwEA_Ej8F3CHybgEE130_provenance.
- NP917856.RAwifiyhNSrlH5bZKJQ4v71h4e4PDwEA_Ej8F3CHybgEE130_assertion wasDerivedFrom befree-20140225 NP917856.RAwifiyhNSrlH5bZKJQ4v71h4e4PDwEA_Ej8F3CHybgEE130_provenance.
- NP917856.RAwifiyhNSrlH5bZKJQ4v71h4e4PDwEA_Ej8F3CHybgEE130_assertion wasGeneratedBy ECO_0000203 NP917856.RAwifiyhNSrlH5bZKJQ4v71h4e4PDwEA_Ej8F3CHybgEE130_provenance.